Laurent Gillet - Infectious Diseases

Author Information

Laurent Gillet is a prominent researcher affiliated with the Immunology-Vaccinology Laboratory, Department of Infectious and Parasitic Diseases (B43b) at FARAH, University of Liège, located in Liège, Belgium. His work primarily focuses on infectious diseases, with a significant emphasis on research related to SARS-CoV-2 and related public health measures, which has been especially pertinent during the COVID-19 pandemic.

Research Contributions

Laurent Gillet has made substantial contributions to the field of infectious diseases with a particular focus on COVID-19. His research spans a wide array of topics including the acceptability and reliability of community saliva testing, scalable qPCR testing methods, and immune response kinetics to COVID-19 vaccines. Additionally, he has explored the efficacy of mass screening in controlling virus transmission in nursing homes and the development of stochastic models for infectious disease screening on university campuses. His work is critical in understanding and managing infectious diseases, contributing valuable insights into public health strategies and vaccine responses.

Aliases

Laurent Gillet is also known by the aliases L Gillet and L. Gillet in various publications and research databases.

Publication and Citation Metrics

Metric	Value
Total Papers	150
Total Citations	3065
h-index	31

Publications:

Acceptability of Community Saliva Testing in Controlling the COVID-19 Pandemic: Lessons Learned from Two Case Studies in Nursing Homes and Schools

DOI: 10.2147/PPA.S349742

Year: 2022

Reliable and Scalable SARS-CoV-2 qPCR Testing at a High Sample Throughput: Lessons Learned from the Belgian Initiative

DOI: 10.3390/life12020159

Year: 2022

Kinetics and persistence of the cellular and humoral immune responses to BNT162b2 mRNA vaccine in SARS-CoV-2-naive and -experienced subjects

DOI: 10.1101/2022.01.17.22269278

Year: 2022

University population-based prospective cohort study of SARS-CoV-2 infection and immunity (SARSSURV-ULiège): a study protocol

DOI: 10.1136/bmjopen-2021-055721

Year: 2022

A hybrid stochastic model and its Bayesian identification for infectious disease screening in a university campus with application to massive COVID-19 screening at the University of Liège

DOI: 10.1016/j.mbs.2022.108805

Year: 2022

In-Depth Longitudinal Comparison of Clinical Specimens to Detect SARS-CoV-2

DOI: 10.3390/pathogens10111362

Year: 2021

Repetitive saliva‐based mass screening as a tool for controlling SARS‐CoV‐2 transmission in nursing homes

DOI: 10.1111/tbed.14280

Year: 2021

A single oral immunization with a replication-competent adenovirus-vectored vaccine protects mice from influenza respiratory infection

DOI: 10.1101/2021.07.21.453241

Year: 2021

The First Random Observational Survey of Barrier Gestures against COVID-19

DOI: 10.3390/ijerph18199972

Year: 2021

IL-20 Cytokines Are Involved in Epithelial Lesions Associated with Virus-Induced COPD Exacerbation in Mice

DOI: 10.3390/biomedicines9121838

Year: 2021

How Do Antivirals Work?

Why Are Masks Important in Infectious Disease Prevention?

What are the Criteria for Eradication?

How Does the FDA Ensure the Safety of Antiviral Drugs?

What are T Cells?

What Role Does Community Engagement Play?

What Are the Challenges in Treating Viral Infections?

What are Some Examples of Structural Proteins in Infectious Diseases?

How is Schistosomiasis Diagnosed?

What are Respiratory Symptoms?

Partnered Content Networks

Relevant Topics